4.7 Article

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

Adriana Bastidas et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Public, Environmental & Occupational Health

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

Kathleen L. Dooling et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Medicine, General & Internal

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

A. L. Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Himal Lal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Herpes Zoster and Postherpetic Neuralgia Surveillance Using Structured Electronic Data

Michael Klompas et al.

MAYO CLINIC PROCEEDINGS (2011)

Article Mathematical & Computational Biology

Accuracy of Conventional and Marginal Structural Cox Model Estimators: A Simulation Study

Yongling Xiao et al.

INTERNATIONAL JOURNAL OF BIOSTATISTICS (2010)

Article Medicine, General & Internal

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

M Mamdani et al.

BMJ-BRITISH MEDICAL JOURNAL (2005)